Inclusion of cancer drug in WHO Covid Solidarity trial: CDSCO panel asks ICMR to submit more clarification Farhat Nasim19 Oct 2020 5:14 PM ISTNew Delhi: The expert panel of the Central Drugs Standard Control Organisation (CDSCO) has recently asked the apex medical research body, Indian...
Price war over Diabetes drug Dapagliflozin: AstraZeneca drags 12 drugmakers to Delhi court Farhat Nasim16 Oct 2020 5:30 PM ISTNew Delhi: Proclaiming a legal battle against 12 Indian drugmakers, AstraZeneca has moved Delhi high court against the dozen firms for eyeing to roll...
AstraZeneca to launch cancer drug Acalabrutinib under brand name Calquence Ruchika Sharma16 Oct 2020 11:25 AM ISTNew Delhi: Drug firm AstraZeneca Pharma India on Thursday said it will launch its Acalabrutinib 100 mg capsules, used for treatment of various types...
AstraZeneca, US strike deal for Covid-19 antibody treatment touted by Trump Ruchika Sharma11 Oct 2020 10:30 AM ISTAstraZeneca said it was planning to supply up to 1,00,000 doses starting toward the end of 2020 and that the U.S. government could acquire up to an...
AstraZeneca COVID vaccine under USFDA safety inquiry Ruchika Sharma2 Oct 2020 10:30 AM ISTWashington: The U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc's Covid-19 vaccine study and...
Serum Institute gets DCGI nod to restart Oxford Vaccine trial with certain conditions Ruchika Sharma17 Sept 2020 11:37 AM ISTDSMB, India, also has recommended to continue the study and enroll the remaining participants in the clinical trial as per protocol subject to certain...
AstraZeneca COVID-19 vaccine trial pause applauded by WHO Ruchika Sharma15 Sept 2020 9:30 AM ISTGeneva: A World Health Organization official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus...
AstraZeneca restarts COVID-19 vaccine trials in UK Ruchika Sharma14 Sept 2020 1:00 PM ISTIt added that safety reviewers had recommended to Britain's Medicines Health Regulatory Authority(MHRA) that it was safe to resume the British trials.
AstraZeneca still aiming for Oxford COVID vaccine by 2020 end, says CEO Ruchika Sharma11 Sept 2020 1:04 PM ISTThe trial was halted after a person in the UK who was participating in it got sick, triggering a review of safety data.
Serum Institute halts COVID vaccine trials in India MD Bureau11 Sept 2020 10:00 AM ISTIn a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We...
Urgently reviewing AstraZeneca COVID-19 vaccine trial data, says Britain medical regulator Ruchika Sharma11 Sept 2020 8:45 AM ISTUK: Britain's medical regulator said on Wednesday it is urgently reviewing information available to determine whether AstraZeneca AZN.L can restart...
Suspension of Covishield trials in UK spells havoc for Astrazeneca and Serum Institute of India Ruchika Sharma10 Sept 2020 1:58 PM ISTNew Delhi: Owing to a suspected severe adverse reaction on a participant after being administered a booster dose of Covishield, the Drugs Controller...
